Biopolis Expansion Confirms Singapore's Growing Role As A Global Biomedical Sciences Hub
The demand for research laboratories at Singapore's Biopolis, a purpose-built biomedical R&D hub, has been so strong that development of phase II is already underway less than 2 years after Biopolis opened. Phase I with 2 million square feet of space is over 90 per cent occupied. Phase II with start with two new buildings providing an additional 400,000 square feet of space to house the R&D operations of pharmaceutical and biotechnology companies.
"The overwhelming demand for spaces at Biopolis leading to the accelerated Phase II development, signals the exponential growth of the biomedical sciences R&D community in Singapore. It bears testimony to Singapore's success in building a world-class R&D environment," said Mr Yeoh Keat Chuan, Deputy Director, Biomedical Sciences Group of the Singapore Economic Development Board.
Companies are eager to take advantage of the shared facilities at Biopolis, where researchers are able to access state-of-art scientific infrastructure and specialised services. These include DNA sequencing, proteomics, nuclear magnetic resonance, flow cytometry, x-ray crystallography, histology, confocal microscopy, microarrays and others. As a result, companies are able to cut R&D costs significantly and accelerate product development. In addition, there are conference facilities and meeting rooms as well as centralised laboratory support services including media preparation, lab supplies and glassware washing.
Other news from the department manufacturing
These products might interest you
Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications
Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Last viewed contents
MDS Pharma Services Strengthens Therapeutic Focus on Respiratory and Metabolic Disorders - Dr. Bernard Tisserand and Dr. Jonny Salyer appointed Executive Medical Directors to provide leadership and expertise for late stage clinical studies
Sanofi Pasteur and Butantan Institute to Provide A(H1N1) Vaccine to Brazilian Government - Initial supply of 18 million doses of A(H1N1) influenza vaccine
A Trojan Horse delivery for treating a rare, potentially deadly, blood-clotting disorder - In this possible treatment, platelet blood cells carry an enzyme needed to prevent clots in TTP, while hiding the enzyme from autoantibody neutralization
CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform
Novel HCMV compound of AiCuris in phase IIb trial with bone marrow transplant recipients
Basilea receives milestone payment from distribution agreement for Toctino with Almirall
Biotage AB and McMaster University sign joint agreement to develop new chemistry platform
Asia-Pacific continues to drive global healthcare investment, innovation and growth ASEAN - A US$150 billion healthcare market by 2017, says Frost & Sullivan
Pharmacogenomics study finds rare gene variants critical for personalized drug treatment
